diarrhea/neoplasms

FIELD OF THE INVENTION The present invention relates to camptothecin compounds, in particular, irinotecan hydrochloride composition formulations, and methods of administering camptothecin compounds such as irinotecan hydrochloride for the treatment of cancer and AIDS, with reduced side

FIELD OF THE INVENTION The present invention relates to camptothecin compounds, in particular, irinotecan hydrochloride composition formulations, and methods of administering camptothecin compounds such as irinotecan hydrochloride for the treatment of cancer and AIDS, with reduced side

FIELD OF THE INVENTION The invention is generally related to pharmaceutical compositions and methods of treating disorders of the digestive tract, in particular inflammatory disorders, cancer, and diarrhea. BACKGROUND OF THE INVENTION Diarrhea and inflammatory gut disorders are a major and

TECHNICAL FIELD The present invention relates to an agent for preventing and treating diarrhea, and particularly to a pharmaceutical agent for preventing and treating a diarrheic symptom caused by administration of cancer chemotherapeutics. BACKGROUND ART Diarrhea often develops as a side-effect

BACKGROUND OF THE INVENTION The invention relates generally to the use of sesquiterpene lactones in the treatment of infections caused by Flaviviridae and, more specifically, to the use of sesquiterpene lactone endoperoxides to treat hepatitis C infections, yellow fever, dengue fever, bovine viral

BACKGROUND 1. Field of the Invention The teachings provided herein relate to methods of treating gastrointestinal spasms. 2. Description of Related Art Antispasmodics can be used to prevent spasms of the stomach, intestine, uterus, or urinary bladder. Gastrointestinal spasms, for example, can be

FIELD OF INVENTION The present invention relates generally to methods of treating disorders such as AIDS, arthritis (rheumatoid arthritis, osteoarthritis, spondyloarthropathies), antibiotic induced diarrheal diseases (Clostridium difficile), multiple sclerosis, osteoporosis, gingivitis, peptic ulcer

BACKGROUND 1. Field of the Invention The teachings provided herein relate to methods of treating gastrointestinal spasms. 2. Description of Related Art Antispasmodics can be used to prevent spasms of the stomach, intestine, uterus, or urinary bladder. Gastrointestinal spasms, for example, can be

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to the field of piezoelectric sensors and their use for detecting organic compounds. In particular, the present invention is directed to piezoelectric plate sensors capable of detecting organic compounds in a

BACKGROUND OF THE INVENTION The present invention is directed to compounds and compositions containing said compounds which bind selectively to somatostatin receptor subtypes and the use of said compounds for treating medical disorders which are mediated by somatostatin receptor subtypes.

FIELD OF INVENTION This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of

This application is a .sctn. 371 of International Application No. PCT/IB2015/056905, filed 9 Sep. 2015, which claims the priority of PCT/CN2015/086995, filed 14 Aug. 2015, and PCT/CN2014/086197, filed 10 Sep. 2014, which are incorporated herein in their entireties. FIELD OF INVENTION This invention

FIELD OF INVENTION This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of

FIELD OF INVENTION This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of

FIELD OF INVENTION This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of